Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

What To Know About State-Level PBM Reform No Photo Available

Healthcare attorneys are keeping a close eye on new laws focused on the vertical integration of pharmacy benefit managers.

No Slowdown: A Midyear Look At FDA Ad Enforcement No Photo Available

An FDA drug ad enforcement surge that began last year continued in the first half of 2026. Experts say the agency is looking hard at t... (more story)

What To Know About The Missouri Abortion Law Ruling No Photo Available

Nearly two years after Missouri residents enshrined reproductive rights into the state constitution, a judge ruled that more than thre... (more story)